Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
PLoS Med
    April 2024
  1. JUNG SM, Loo SL, Howerton E, Contamin L, et al
    Potential impact of annual vaccination with reformulated COVID-19 vaccines: Lessons from the US COVID-19 scenario modeling hub.
    PLoS Med. 2024;21:e1004387.
    >> Share

  2. ELIGULASHVILI A, Gordon M, Lee JS, Lee J, et al
    Long-term outcomes of hospitalized patients with SARS-CoV-2/COVID-19 with and without neurological involvement: 3-year follow-up assessment.
    PLoS Med. 2024;21:e1004263.
    >> Share

    February 2024
  3. NICKEL NC, Phillips-Beck W, Enns JE, Ekuma O, et al
    COVID-19 diagnostic testing and vaccinations among First Nations in Manitoba: A nations-based retrospective cohort study using linked administrative data, 2020-2021.
    PLoS Med. 2024;21:e1004348.
    >> Share

  4. MKOMA GF, Agyemang C, Benfield T, Rostila M, et al
    Risk of long COVID and associated symptoms after acute SARS-COV-2 infection in ethnic minorities: A nationwide register-linked cohort study in Denmark.
    PLoS Med. 2024;21:e1004280.
    >> Share

    January 2024
  5. GHARPURE R, Chard AN, Cabrera Escobar M, Zhou W, et al
    Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
    PLoS Med. 2024;21:e1004333.
    >> Share

  6. PANAGI L, White SR, Pinto Pereira SM, Nugawela MD, et al
    Mental health in the COVID-19 pandemic: A longitudinal analysis of the CLoCk cohort study.
    PLoS Med. 2024;21:e1004315.
    >> Share

    December 2023
  7. LEBLANC J, Dusserre-Telmon L, Chauvin A, Simon T, et al
    Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.
    PLoS Med. 2023;20:e1004317.
    >> Share

    November 2023
  8. HOGAN AB, Wu SL, Toor J, Olivera Mesa D, et al
    Long-term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: A modelling study.
    PLoS Med. 2023;20:e1004195.
    >> Share

  9. CARTULIARES MB, Rosenvinge FS, Mogensen CB, Skovsted TA, et al
    Evaluation of point-of-care multiplex polymerase chain reaction in guiding antibiotic treatment of patients acutely admitted with suspected community-acquired pneumonia in Denmark: A multicentre randomised controlled trial.
    PLoS Med. 2023;20:e1004314.
    >> Share

    September 2023
  10. WATKINSON RE, Williams R, Gillibrand S, Munford L, et al
    Evaluating socioeconomic inequalities in influenza vaccine uptake during the COVID-19 pandemic: A cohort study in Greater Manchester, England.
    PLoS Med. 2023;20:e1004289.
    >> Share

  11. KUCHARSKI AJ, Chung K, Aubry M, Teiti I, et al
    Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening: An observational study.
    PLoS Med. 2023;20:e1004283.
    >> Share

    July 2023
  12. XIONG X, Lui DTW, Chung MSH, Au ICH, et al
    Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    PLoS Med. 2023;20:e1004274.
    >> Share

  13. HILLARY RF, McCartney DL, Smith HM, Bernabeu E, et al
    Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.
    PLoS Med. 2023;20:e1004247.
    >> Share

  14. ANTILLON M, Li X, Willem L, Bilcke J, et al
    The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach.
    PLoS Med. 2023;20:e1004250.
    >> Share

    June 2023
  15. STOWE J, Miller E, Andrews N, Whitaker HJ, et al
    Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    PLoS Med. 2023;20:e1004245.
    >> Share

  16. SMITH DRM, Shirreff G, Temime L, Opatowski L, et al
    Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study.
    PLoS Med. 2023;20:e1004240.
    >> Share

  17. QIN K, Honjo K, Sherrill-Mix S, Liu W, et al
    Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study.
    PLoS Med. 2023;20:e1004157.
    >> Share

  18. MARINCOWITZ C, Bouamra O, Coats T, Surendra Kumar D, et al
    Major trauma presentations and patient outcomes in English hospitals during the COVID-19 pandemic: An observational cohort study.
    PLoS Med. 2023;20:e1004243.
    >> Share

    May 2023
  19. MARTINSON NA, Nonyane BAS, Genade LP, Berhanu RH, et al
    Evaluating systematic targeted universal testing for tuberculosis in primary care clinics of South Africa: A cluster-randomized trial (The TUTT Trial).
    PLoS Med. 2023;20:e1004237.
    >> Share

  20. BANHOLZER N, Zurcher K, Jent P, Bittel P, et al
    SARS-CoV-2 transmission with and without mask wearing or air cleaners in schools in Switzerland: A modeling study of epidemiological, environmental, and molecular data.
    PLoS Med. 2023;20:e1004226.
    >> Share

    April 2023
  21. MORENO-AGOSTINO D, Fisher HL, Goodman A, Hatch SL, et al
    Long-term psychological distress trajectories and the COVID-19 pandemic in three British birth cohorts: A multi-cohort study.
    PLoS Med. 2023;20:e1004145.
    >> Share

  22. SAXENA S, Chwa C
    Mental disorders and COVID-19 deaths: Clinical, public health, and human rights implications.
    PLoS Med. 2023;20:e1004220.
    >> Share

  23. VIOLATO M, Pollard J, Lloyd A, Roope LSJ, et al
    The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: A cross-sectional analysis.
    PLoS Med. 2023;20:e1004146.
    >> Share

  24. TOMLINSON M, Marlow M
    COVID-19 and mental health: Building back better or reimagining a new way forward?
    PLoS Med. 2023;20:e1004216.
    >> Share

  25. AKSUNGER N, Vernot C, Littman R, Voors M, et al
    COVID-19 and mental health in 8 low- and middle-income countries: A prospective cohort study.
    PLoS Med. 2023;20:e1004081.
    >> Share

  26. PINTO DA COSTA M, Stewart R
    Investigating time-dependent COVID-19 pandemic mental health data: Challenges and opportunities of using panel data analysis.
    PLoS Med. 2023;20:e1004219.
    >> Share

  27. MYRAN DT, Roberts R, McArthur E, Jeyakumar N, et al
    Mental health and addiction health service use by physicians compared to non-physicians before and during the COVID-19 pandemic: A population-based cohort study in Ontario, Canada.
    PLoS Med. 2023;20:e1004187.
    >> Share

  28. BU F, Steptoe A, Fancourt D
    Depressive and anxiety symptoms in adults during the COVID-19 pandemic in England: A panel data analysis over 2 years.
    PLoS Med. 2023;20:e1004144.
    >> Share

  29. WITTEVEEN AB, Young SY, Cuijpers P, Ayuso-Mateos JL, et al
    COVID-19 and common mental health symptoms in the early phase of the pandemic: An umbrella review of the evidence.
    PLoS Med. 2023;20:e1004206.
    >> Share

  30. BEACH B, Steptoe A, Zaninotto P
    Depression and anxiety in people with cognitive impairment and dementia during the COVID-19 pandemic: Analysis of the English Longitudinal Study of Ageing.
    PLoS Med. 2023;20:e1004162.
    >> Share

  31. PATEL V, Fancourt D, Furukawa TA, Kola L, et al
    Reimagining the journey to recovery: The COVID-19 pandemic and global mental health.
    PLoS Med. 2023;20:e1004224.
    >> Share

  32. WELS J, Wielgoszewska B, Moltrecht B, Booth C, et al
    Home working and social and mental wellbeing at different stages of the COVID-19 pandemic in the UK: Evidence from 7 longitudinal population surveys.
    PLoS Med. 2023;20:e1004214.
    >> Share

  33. FUNG KW, Baye F, Baik SH, Zheng Z, et al
    Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US.
    PLoS Med. 2023;20:e1004194.
    >> Share

  34. ROCKERS PC, Leppanen JM, Tarullo A, Coetzee L, et al
    Evaluation of a community health worker home visit intervention to improve child development in South Africa: A cluster-randomized controlled trial.
    PLoS Med. 2023;20:e1004222.
    >> Share

    February 2023
  35. NORDSTROM P, Ballin M, Nordstrom A
    Safety and effectiveness of monovalent COVID-19 mRNA vaccination and risk factors for hospitalisation caused by the omicron variant in 0.8 million adolescents: A nationwide cohort study in Sweden.
    PLoS Med. 2023;20:e1004127.
    >> Share

  36. DAVISSE-PATURET C, Orri M, Legleye S, Florence AM, et al
    Suicidal ideation following self-reported COVID-19-like symptoms or serology-confirmed SARS-CoV-2 infection in France: A propensity score weighted analysis from a cohort study.
    PLoS Med. 2023;20:e1004171.
    >> Share

  37. GYLLENBERG D, Bastola K, Wan Mohd Yunus WMA, Mishina K, et al
    Comparison of new psychiatric diagnoses among Finnish children and adolescents before and during the COVID-19 pandemic: A nationwide register-based study.
    PLoS Med. 2023;20:e1004072.
    >> Share

  38. SCHWARZINGER M, Luchini S, Teschl M, Alla F, et al
    Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study.
    PLoS Med. 2023;20:e1004134.
    >> Share

    January 2023
  39. TURTLE L, Thorpe M, Drake TM, Swets M, et al
    Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study.
    PLoS Med. 2023;20:e1004086.
    >> Share

  40. HAMILTON FW, Thomas M, Arnold D, Palmer T, et al
    Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A mendelian randomisation study.
    PLoS Med. 2023;20:e1004174.
    >> Share

  41. WAN J, Cazer CL, Clarkberg ME, Henderson SG, et al
    Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study.
    PLoS Med. 2023;20:e1004153.
    >> Share

  42. BOR J, Assoumou SA, Lane K, Diaz Y, et al
    Inequities in COVID-19 vaccine and booster coverage across Massachusetts ZIP codes after the emergence of Omicron: A population-based cross-sectional study.
    PLoS Med. 2023;20:e1004167.
    >> Share

  43. CERQUEIRA-SILVA T, Shah SA, Robertson C, Sanchez M, et al
    Effectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case-control study.
    PLoS Med. 2023;20:e1004156.
    >> Share

    December 2022
  44. LIND ML, Robertson AJ, Silva J, Warner F, et al
    Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis.
    PLoS Med. 2022;19:e1004136.
    >> Share

  45. HEINSOHN T, Lange B, Vanella P, Rodiah I, et al
    Infection and transmission risks of COVID-19 in schools and their contribution to population infections in Germany: A retrospective observational study using nationwide and regional health and education agency notification data.
    PLoS Med. 2022;19:e1003913.
    >> Share

    November 2022
  46. BABOUEE FLURY B, Gusewell S, Egger T, Leal O, et al
    Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    PLoS Med. 2022;19:e1004125.
    >> Share

  47. SUTHAR AB, Dye C
    Infection, immunity, and surveillance of COVID-19.
    PLoS Med. 2022;19:e1004132.
    >> Share

  48. BERGERI I, Whelan MG, Ware H, Subissi L, et al
    Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies.
    PLoS Med. 2022;19:e1004107.
    >> Share

  49. ROESSLER M, Tesch F, Batram M, Jacob J, et al
    Post-COVID-19-associated morbidity in children, adolescents, and adults: A matched cohort study including more than 157,000 individuals with COVID-19 in Germany.
    PLoS Med. 2022;19:e1004122.
    >> Share

  50. BERTRAN M, Amin-Chowdhury Z, Davies HG, Allen H, et al
    COVID-19 deaths in children and young people in England, March 2020 to December 2021: An active prospective national surveillance study.
    PLoS Med. 2022;19:e1004118.
    >> Share

  51. NIELSEN KF, Moustsen-Helms IR, Schelde AB, Gram MA, et al
    Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    PLoS Med. 2022;19:e1004037.
    >> Share

    October 2022
  52. LOWE DM, Brown LK, Chowdhury K, Davey S, et al
    Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 x 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19.
    PLoS Med. 2022;19:e1004120.
    >> Share

  53. HENSLEY KS, Jongkees MJ, Geers D, GeurtsvanKessel CH, et al
    Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study.
    PLoS Med. 2022;19:e1003979.
    >> Share

    September 2022
  54. GRAM MA, Emborg HD, Schelde AB, Friis NU, et al
    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    PLoS Med. 2022;19:e1003992.
    >> Share

  55. FOFANA MO, Nery N Jr, Aguilar Ticona JP, de Andrade Belitardo EMM, et al
    Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
    PLoS Med. 2022;19:e1004093.
    >> Share

    August 2022
  56. SAARINEN S, Moustgaard H, Remes H, Sallinen R, et al
    Income differences in COVID-19 incidence and severity in Finland among people with foreign and native background: A population-based cohort study of individuals nested within households.
    PLoS Med. 2022;19:e1004038.
    >> Share

  57. KIM S, Headley TY, Tozan Y
    Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries.
    PLoS Med. 2022;19:e1004060.
    >> Share

  58. AHMED T, Roberton T, Vergeer P, Hansen PM, et al
    Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data.
    PLoS Med. 2022;19:e1004070.
    >> Share

  59. MODY A, Bradley C, Redkar S, Fox B, et al
    Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.
    PLoS Med. 2022;19:e1004048.
    >> Share

  60. NIJMAN RG, Honeyford K, Farrugia R, Rose K, et al
    Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
    PLoS Med. 2022;19:e1003974.
    >> Share

    July 2022
  61. REZEL-POTTS E, Douiri A, Sun X, Chowienczyk PJ, et al
    Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
    PLoS Med. 2022;19:e1004052.
    >> Share

  62. COBB NL, Collier S, Attia EF, Augusto O, et al
    Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.
    PLoS Med. 2022;19:e1004035.
    >> Share

  63. SHIBUYA K, Tan CC, Chun AY, Leung GM, et al
    Global human security in the post-COVID-19 era: The rising role of East Asia.
    PLoS Med. 2022;19:e1003939.
    >> Share

  64. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
    Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    PLoS Med. 2022;19:e1004069.
    >> Share

  65. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
    Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    PLoS Med. 2022;19:e1004056.
    >> Share

    June 2022
  66. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
    Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
    PLoS Med. 2022;19:e1004024.
    >> Share

  67. WONG CKH, Lau KTK, Xiong X, Au ICH, et al
    Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    PLoS Med. 2022;19:e1004018.
    >> Share

  68. CUIJPERS P, Heim E, Abi Ramia J, Burchert S, et al
    Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
    PLoS Med. 2022;19:e1004025.
    >> Share

  69. GRAIS RF, Baron E
    Addressing the impacts of COVID-19 on refugee health.
    PLoS Med. 2022;19:e1004050.
    >> Share

    May 2022
  70. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    >> Share

  71. JIN P, Guo X, Chen W, Ma S, et al
    Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
    PLoS Med. 2022;19:e1003953.
    >> Share

  72. VAN GILS MJ, Lavell A, van der Straten K, Appelman B, et al
    Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
    PLoS Med. 2022;19:e1003991.
    >> Share

  73. ALTARE C, Kostandova N, OKeeffe J, Hayek H, et al
    COVID-19 epidemiology and changes in health service utilization in Azraq and Zaatari refugee camps in Jordan: A retrospective cohort study.
    PLoS Med. 2022;19:e1003993.
    >> Share

  74. ANNWEILER C, Beaudenon M, Gautier J, Gonsard J, et al
    High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    PLoS Med. 2022;19:e1003999.
    >> Share

  75. BUITRAGO-GARCIA D, Ipekci AM, Heron L, Imeri H, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003987.
    >> Share

  76. MACHADO DB, Williamson E, Pescarini JM, Alves FJO, et al
    Relationship between the Bolsa Familia national cash transfer programme and suicide incidence in Brazil: A quasi-experimental study.
    PLoS Med. 2022;19:e1004000.
    >> Share

  77. BRUMMER LE, Katzenschlager S, McGrath S, Schmitz S, et al
    Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors.
    PLoS Med. 2022;19:e1004011.
    >> Share

    April 2022
  78. FOO D, Sarna M, Pereira G, Moore HC, et al
    Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.
    PLoS Med. 2022;19:e1003963.
    >> Share

  79. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Correction: Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003982.
    >> Share

  80. WAINSTEIN M, MacDonald S, Fryer D, Young K, et al
    Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    PLoS Med. 2022;19:e1003969.
    >> Share

    March 2022
  81. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003932.
    >> Share

  82. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    >> Share

  83. MAURIN C, He Z, Mentek M, Verhoeven P, et al
    Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    PLoS Med. 2022;19:e1003922.
    >> Share

  84. GIMMA A, Munday JD, Wong KLM, Coletti P, et al
    Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study.
    PLoS Med. 2022;19:e1003907.
    >> Share

    February 2022
  85. SAAKSVUORI L, Betsch C, Nohynek H, Salo H, et al
    Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland.
    PLoS Med. 2022;19:e1003919.
    >> Share


  86. Vaccine equity: A fundamental imperative in the fight against COVID-19.
    PLoS Med. 2022;19:e1003948.
    >> Share

  87. KONTOPANTELIS E, Mamas MA, Webb RT, Castro A, et al
    Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
    PLoS Med. 2022;19:e1003904.
    >> Share

  88. CAUSEY K, Mosser JF
    Learning from the COVID-19 pandemic to strengthen routine immunization systems.
    PLoS Med. 2022;19:e1003934.
    >> Share

  89. MCQUAID F, Mulholland R, Sangpang Rai Y, Agrawal U, et al
    Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
    PLoS Med. 2022;19:e1003916.
    >> Share

  90. KERR S, Joy M, Torabi F, Bedston S, et al
    First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
    PLoS Med. 2022;19:e1003927.
    >> Share

    January 2022
  91. GENTILE I, Schiano Moriello N
    COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination.
    PLoS Med. 2022;19:e1003917.
    >> Share

  92. STRONGMAN H, Carreira H, De Stavola BL, Bhaskaran K, et al
    Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    PLoS Med. 2022;19:e1003870.
    >> Share

  93. BHASKARAN K, Rentsch CT, Hickman G, Hulme WJ, et al
    Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    PLoS Med. 2022;19:e1003871.
    >> Share

  94. QUINN KL, Bell CM
    Pandemic health consequences: Grasping the long COVID tail.
    PLoS Med. 2022;19:e1003891.
    >> Share

  95. GUROL-URGANCI I, Waite L, Webster K, Jardine J, et al
    Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study.
    PLoS Med. 2022;19:e1003884.
    >> Share

    December 2021
  96. GRAM MA, Nielsen J, Schelde AB, Nielsen KF, et al
    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003874.
    >> Share

  97. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    >> Share

  98. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    >> Share

  99. PETERSEN M, Schwab J, Havlir DV
    SARS-CoV-2 vaccine boosters: The time to act is now.
    PLoS Med. 2021;18:e1003882.
    >> Share

  100. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003877.
    >> Share

  101. SENEFELD JW, Johnson PW, Kunze KL, Bloch EM, et al
    Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
    PLoS Med. 2021;18:e1003872.
    >> Share

    November 2021
  102. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    >> Share

  103. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
    Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
    PLoS Med. 2021;18:e1003826.
    >> Share

  104. EPELBOIN S, Labrosse J, De Mouzon J, Fauque P, et al
    Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
    PLoS Med. 2021;18:e1003857.
    >> Share

  105. ABDOOL KARIM SS, Kelemu S, Baxter C
    COVID-19 in Africa: Catalyzing change for sustainable development.
    PLoS Med. 2021;18:e1003869.
    >> Share

  106. SPLINTER MJ, Velek P, Ikram MK, Kieboom BCT, et al
    Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003854.
    >> Share

    October 2021
  107. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    >> Share

  108. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    PLoS Med. 2021;18:e1003815.
    >> Share

  109. FORMICA N, Mallory R, Albert G, Robinson M, et al
    Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
    PLoS Med. 2021;18:e1003769.
    >> Share

  110. BERGQVIST R, Ahlqvist VH, Lundberg M, Hergens MP, et al
    HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
    PLoS Med. 2021;18:e1003820.
    >> Share

  111. GILBODY S, Littlewood E, McMillan D, Chew-Graham CA, et al
    Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial.
    PLoS Med. 2021;18:e1003779.
    >> Share

  112. MO Y, Eyre DW, Lumley SF, Walker TM, et al
    Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
    PLoS Med. 2021;18:e1003816.
    >> Share

  113. IOANNOU GN, Ferguson JM, O'Hare AM, Bohnert ASB, et al
    Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    PLoS Med. 2021;18:e1003807.
    >> Share

  114. POLLETT S, Johansson MA, Reich NG, Brett-Major D, et al
    Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
    PLoS Med. 2021;18:e1003793.
    >> Share

  115. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    >> Share

    September 2021
  116. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
    Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    PLoS Med. 2021;18:e1003772.
    >> Share

  117. MUTHUKUMAR AV, Morrell W, Bierer BE
    Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
    PLoS Med. 2021;18:e1003758.
    >> Share

  118. ELLIOTT J, Whitaker M, Bodinier B, Eales O, et al
    Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    PLoS Med. 2021;18:e1003777.
    >> Share

  119. TAQUET M, Dercon Q, Luciano S, Geddes JR, et al
    Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    PLoS Med. 2021;18:e1003773.
    >> Share

  120. ADAM M, Johnston J, Job N, Dronavalli M, et al
    Evaluation of a community-based mobile video breastfeeding intervention in Khayelitsha, South Africa: The Philani MOVIE cluster-randomized controlled trial.
    PLoS Med. 2021;18:e1003744.
    >> Share

    August 2021
  121. BRUMMER LE, Katzenschlager S, Gaeddert M, Erdmann C, et al
    Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003735.
    >> Share

  122. KILMARX PH, Glass RI
    Building global health research capacity to address research imperatives following the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003753.
    >> Share

    July 2021
  123. SULIS G, Batomen B, Kotwani A, Pai M, et al
    Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    PLoS Med. 2021;18:e1003682.
    >> Share

  124. IWANAMI S, Ejima K, Kim KS, Noshita K, et al
    Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
    PLoS Med. 2021;18:e1003660.
    >> Share

  125. KANDULA S, Shaman J
    Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
    PLoS Med. 2021;18:e1003693.
    >> Share

    June 2021
  126. BUTLER-LAPORTE G, Nakanishi T, Mooser V, Morrison DR, et al
    Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    PLoS Med. 2021;18:e1003605.
    >> Share

  127. INZAULE SC, Ondoa P, Loembe MM, Tebeje YK, et al
    COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
    PLoS Med. 2021;18:e1003666.
    >> Share

  128. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    >> Share

    May 2021
  129. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    >> Share

  130. STOKES AC, Lundberg DJ, Elo IT, Hempstead K, et al
    COVID-19 and excess mortality in the United States: A county-level analysis.
    PLoS Med. 2021;18:e1003571.
    >> Share

    April 2021
  131. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    >> Share

  132. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
    Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003604.
    >> Share

  133. GRANTZ KH, Lee EC, D'Agostino McGowan L, Lee KH, et al
    Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study.
    PLoS Med. 2021;18:e1003585.
    >> Share

    March 2021
  134. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
    Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003550.
    >> Share

  135. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    >> Share

  136. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
    How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    PLoS Med. 2021;18:e1003564.
    >> Share

  137. LEONG A, Cole JB, Brenner LN, Meigs JB, et al
    Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    PLoS Med. 2021;18:e1003553.
    >> Share

    January 2021
  138. SELIGMAN B, Ferranna M, Bloom DE
    Social determinants of mortality from COVID-19: A simulation study using NHANES.
    PLoS Med. 2021;18:e1003490.
    >> Share

    December 2020
  139. KIM MS, An MH, Kim WJ, Hwang TH, et al
    Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    PLoS Med. 2020;17:e1003501.
    >> Share

    October 2020
  140. MAKARONIDIS J, Mok J, Balogun N, Magee CG, et al
    Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    PLoS Med. 2020;17:e1003358.
    >> Share

  141. MCKEIGUE PM, Weir A, Bishop J, McGurnaghan SJ, et al
    Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    PLoS Med. 2020;17:e1003374.
    >> Share

  142. BASSETT MT, Chen JT, Krieger N
    Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    PLoS Med. 2020;17:e1003402.
    >> Share

  143. KOLHE NV, Fluck RJ, Selby NM, Taal MW, et al
    Acute kidney injury associated with COVID-19: A retrospective cohort study.
    PLoS Med. 2020;17:e1003406.
    >> Share

    September 2020
  144. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003346.
    >> Share

  145. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
    Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    PLoS Med. 2020;17:e1003379.
    >> Share

  146. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    >> Share

  147. STOWE J, Andrews N, Gringras P, Quinnell T, et al
    Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    PLoS Med. 2020;17:e1003225.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016